Chairman, Option Fund at Novartis Venture Fund
Spyros Artavanis-Tsakonas, Ph.D., is our Chief Scientific Officer, having joined in March 2012.
Spyros Artavanis-Tsakonas, Ph.D., is our Chief Scientific Officer, having joined in March 2012. Dr. Artavanis-Tsakonas is Professor of Cell ...